A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex. (Q54535857)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

title

A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

main subject

tuberous sclerosis

1 reference

based on heuristic

inferred from title

sirolimus

1 reference

based on heuristic

inferred from title

author name string

Mari Wataya-Kaneda

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Mari Tanaka

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Ayumi Nakamura

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Shoji Matsumoto

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Ichiro Katayama

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

publication date

1 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

published in

Archives of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

volume

148

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

page(s)

138-139

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Identifiers

DOI

10.1001/ARCHDERM.148.1.138

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

Fatcat ID

release_izhtzrrqajhtzjv3d3im6hna7y

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/izhtzrrqajhtzjv3d3im6hna7y

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

22250258

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22250258

retrieved

31 May 2018

reference URL

http://europepmc.org/abstract/MED/22250258

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54535857&oldid=1838676462"